Cargando…

Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia, through a Six-Year Infection Control Program in a Hospital

Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a life-threatening healthcare-associated infection affecting especially patients with immunosuppression and comorbidities. We investigated the association between the incidence of CRPA bacteremia, antibiotic consumption, and infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papanikolopoulou, Amalia, Gargalianos-Kakolyris, Panagiotis, Stoupis, Athina, Moussas, Nikos, Pangalis, Anastasia, Theodoridou, Kalliopi, Chronopoulou, Genovefa, Pantazis, Nikos, Kantzanou, Maria, Maltezou, Helena C., Tsakris, Athanasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220838/ https://www.ncbi.nlm.nih.gov/pubmed/37317288 http://dx.doi.org/10.3390/microorganisms11051315

Ejemplares similares

Ventilator-Associated Pneumonia, Multidrug-Resistant Bacteremia and Infection Control Interventions in an Intensive Care Unit: Analysis of Six-Year Time-Series Data
por: Papanikolopoulou, Amalia, et al.
Publicado: (2022)

Catheter-Associated Urinary Tract Infections, Bacteremia, and Infection Control Interventions in a Hospital: A Six-Year Time-Series Study
por: Papanikolopoulou, Amalia, et al.
Publicado: (2022)

COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature
por: Maltezou, Helena C., et al.
Publicado: (2023)

Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance
por: Maltezou, Helena C., et al.
Publicado: (2023)

Isolated splenic cystic echinococcosis and albendazole hepatotoxicity
por: Moussas, Nikolaos, et al.
Publicado: (2022)

In-flight transmission of COVID-19 on flights to Greece: An epidemiological analysis
por: Pavli, Androula, et al.
Publicado: (2020)

Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
por: Boufidou, Fotini, et al.
Publicado: (2023)

Prevalence of visceral leishmaniasis among people with HIV: a systematic review and meta-analysis
por: Kantzanou, Maria, et al.
Publicado: (2022)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

Prevalence of Intestinal Parasitic Infections among Children in Europe over the Last Five Years
por: Kantzanou, Maria, et al.
Publicado: (2021)

Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients
por: Pitiriga, Vassiliki, et al.
Publicado: (2022)

Comparison of microbial colonization rates between central venous catheters and peripherally inserted central catheters
por: Pitiriga, Vassiliki, et al.
Publicado: (2023)

Influenza immunization and COVID-19
por: Maltezou, Helena C., et al.
Publicado: (2020)

Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies
por: Zhang, Yu, et al.
Publicado: (2016)

Post-COVID Syndrome: An Insight on Its Pathogenesis
por: Maltezou, Helena C., et al.
Publicado: (2021)

Mortality associated with carbapenem-susceptible and Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa bacteremia
por: Persoon, Marjolein C., et al.
Publicado: (2020)

SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination
por: Pitiriga, Vassiliki C., et al.
Publicado: (2023)

Bacteremia due to carbapenem-resistant Citrobacter braakii
por: Prasanna, Vardhan, et al.
Publicado: (2022)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

304. Predictors of mortality in carbapenem-resistant Enterobacteriales bacteremia
por: Hovan, Michael R, et al.
Publicado: (2020)

Vaccination of health‐care workers against influenza: our obligation to protect patients
por: Maltezou, Helena C., et al.
Publicado: (2011)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines
por: Maltezou, Helena C., et al.
Publicado: (2022)

Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study
por: Terahara, Fumitaka, et al.
Publicado: (2019)

Consumption of antibiotics by children in Greece: a cross-sectional study
por: Maltezou, Helena C., et al.
Publicado: (2017)

Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
por: Fukuchi, Takahiko, et al.
Publicado: (2016)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems
por: Haenni, Marisa, et al.
Publicado: (2017)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort
por: Pantazis, Nikos, et al.
Publicado: (2018)

Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression
por: Petrocheilou, Argyri, et al.
Publicado: (2017)

Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality
por: Kim, Seong Eun, et al.
Publicado: (2012)

The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies
por: Park, Kyung-Hwa, et al.
Publicado: (2013)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018)

Successful treatment of hypervirulent Klebsiella pneumoniae bacteremia with combination carbapenem and rifampicin
por: Lin, Yong-Chun, et al.
Publicado: (2021)

Determinants of intention to get vaccinated against COVID-19 among healthcare personnel in hospitals in Greece
por: Maltezou, Helena C., et al.
Publicado: (2021)

Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
por: Choi, Yongsoon, et al.
Publicado: (2018)

Pseudomonas aeruginosa bacteremia among liver transplant recipients
por: Liu, Taohua, et al.
Publicado: (2018)

Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals
por: Pavli, Androula, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cl70r9465b0nm1vbjabv3k5u8l